close-out of derivatives position; (6) Fees charged on the derivatives transaction. Clause 4. Derivatives broker must show in the evidence of margin call at least the information as set out under Clause 3
requirement by the Bank of Thailand with the capital adequacy ratio as of end of March 2021 at 16.75%. For Capital market business, the market share (SET and mai excluding proprietary trading) of Kiatnakin
สำหรับการคำนวณค่าสถิติมูลค่าตลาดรวม (SET Market capitalization) และดัชนีราคาตลาดหลักทรัพย์ (SET Index) นั้น ตลาดหลักทรัพย์จะนำมูลค่าตลาดของหน่วยลงทุนของกองทุนรวมอสังหาริมทรัพย์มารวมในการคำนวณมูลค่าตลาดรวม
position; (6) Fees charged on the derivatives transaction. Clause 4. Derivatives broker must show in the evidence of margin call at least the information as set out under Clause 3(1) and (3) as well as the
สำหรับการคำนวณค่าสถิติมูลค่าตลาดรวม (SET Market capitalization) และดัชนีราคาตลาดหลักทรัพย์ (SET Index) นั้น ตลาดหลักทรัพย์จะนำมูลค่าตลาดของหน่วยลงทุนของกองทุนรวมอสังหาริมทรัพย์มารวมในการคำนวณมูลค่าตลาดรวม
operating results of the Company in the year 2018 decreased comparing to last year. For your consideration to the members of The Stock Exchange of Thailand and those interested to be informed accordingly
www.ucity.co.th Ref U. SET 022/2017 13 November 2017 Subject: Summary of Operating Performance and Financial Status for Quarter 3/2017 To: President The Stock Exchange of Thailand U City Public Company Limited and
Exchange of Thailand U City Public Company Limited and its subsidiaries (the “Company”) has recently submitted the reviewed interim financial statements for the period ended 31 December 2017 to the Stock
of the Ministry of Natural Resources and Environment, Securities and Exchange Commission, and Stock Exchange of Thailand, with the pilot period of 2 months from May to June 2020. There were 10
ordinary shares of Modern Pharma Company Limited is a subsidiary of the Company, the Company, therefore, has a duty to disclose the transaction information of the Company to the Stock Exchange of Thailand